Propanc Biopharma, Inc. Common Stock (PPCB) — Financial Flexibility Index
Propanc Biopharma, Inc. Common Stock (PPCB) has a Financial Flexibility Index of -0.21x as of December 2025. Free cash flow of $-996.87K (operating CF $-999.14K minus capex $2.27K) represents 0% of total liabilities ($4.66 Million). Also explore net asset momentum of Propanc Biopharma, Inc. Common Stock to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Propanc Biopharma, Inc. Common Stock Financial Flexibility Index (2010–2025)
Historical Financial Flexibility Index trend for Propanc Biopharma, Inc. Common Stock across 16 annual periods. Check Propanc Biopharma, Inc. Common Stock PP&E and investment ratio to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Propanc Biopharma, Inc. Common Stock (2010–2025)
Year-by-year free cash flow to debt coverage for Propanc Biopharma, Inc. Common Stock. For the full company profile including market capitalisation, see how much is Propanc Biopharma, Inc. Common Stock worth.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.07x | $-405.17K | $-405.17K | $5.73 Million | ▲ +70.9% |
| 2024 | -0.24x | $-935.12K | $-935.12K | $3.85 Million | ▲ +30.2% |
| 2023 | -0.35x | $-1.11 Million | $-1.11 Million | $3.18 Million | ▲ +24.8% |
| 2022 | -0.46x | $-1.44 Million | $-1.44 Million | $3.11 Million | ▼ -24.4% |
| 2021 | -0.37x | $-1.15 Million | $-1.15 Million | $3.08 Million | ▲ +24.8% |
| 2020 | -0.49x | $-1.85 Million | $-1.85 Million | $3.74 Million | ▼ -5.8% |
| 2019 | -0.47x | $-2.06 Million | $-2.06 Million | $4.40 Million | — |
| 2018 | 0.00x | $0.00 | $-2.18 Million | $6.82 Million | ▲ +100.0% |
| 2017 | -0.39x | $-2.15 Million | $-2.15 Million | $5.54 Million | ▲ +76.1% |
| 2016 | -1.63x | $-4.79 Million | $-4.80 Million | $2.94 Million | ▼ -320.9% |
| 2015 | -0.39x | $-1.42 Million | $-1.43 Million | $3.68 Million | ▼ -159.8% |
| 2014 | -0.15x | $-226.44K | $-226.44K | $1.52 Million | ▲ +8.2% |
| 2013 | -0.16x | $-128.64K | $-128.65K | $794.22K | ▲ +44.4% |
| 2012 | -0.29x | $-170.28K | $-170.28K | $584.19K | ▲ +93.6% |
| 2011 | -4.54x | $-1.39 Million | $-1.40 Million | $306.85K | ▼ -446.6% |
| 2010 | -0.83x | $-191.51K | $-191.51K | $230.76K | — |